Long-term effects of birth weight and breastfeeding duration on inflammation in early adulthood

Proceedings of the Royal Society B: Biological Sciences

Volumn 281, Issue 1784, 2014, Pages

  McDade, Thomas W ^a   Metzger, Molly W ^b   Chyu, Laura ^a   Duncan, Greg J ^c   Garfield, Craig ^a,d   Adam, Emma K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Developmental origins of health and disease; Health disparities; Inflammation; Population health

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; BIOACCUMULATION; BIOMARKER; BODY MASS; BREASTFEEDING; CARDIOVASCULAR DISEASE; DIGESTIVE SYSTEM DISORDER; HEALTH RISK; HEALTH STATUS; LONG-TERM CHANGE; PROTEIN; PUBLIC HEALTH; RISK FACTOR;

ADULT; BIRTH WEIGHT; BLOOD; BREAST FEEDING; COHORT ANALYSIS; DRIED BLOOD SPOT TESTING; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INFLAMMATION; MALE; METABOLISM; UNITED STATES; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; BLOOD; BREAST FEEDING; C-REACTIVE PROTEIN; COHORT STUDIES; DRIED BLOOD SPOT TESTING; EPIDEMIOLOGY; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; MALE; METABOLISM; UNITED STATES; YOUNG ADULT;

EID: 84902682951     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2013.3116     Document Type: Article

References (65)

1. Forsdahl A. 1977 Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br. J. Prev. Soc. Med. 31, 91-95.
2. Kermack WO, McKendrick AG, McKinlay PL. 1934 Death rates in Great Britain and Sweden: some general regularities and their significance. Lancet 226, 698-703. (doi:10.1016/S0140-6736(00) 92530-3)
3. Barker DJP, Osmond C. 1986 Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1, 1077-1081. (doi:10. 1016/S0140-6736(86)91340-1)
4. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. 2008 Effect of in utero and early-life conditions on adult health and disease. N Engl. J. Med. 359, 61-73. (doi:10.1056/ NEJMra0708473)
5. Barker DJ. 1994 Mothers, babies and diseases in later life. London, UK: BMJ Publishing Group.
6. Ridker PM, Cook N. 2004 Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109, 1955-1959. (doi:10.1161/01.cir.0000125690.80303.a8)
7. Pearson TA et al. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 107, 499-511. (doi:10.1161/01.CIR.0000052939.59093.45)
8. Crimmins EM, Finch CE. 2006 Infection, inflammation, height, and longevity. Proc. Natl Acad. Sci. USA 103, 498-503. (doi:10.1073/ pnas.0501470103)
9. Miller GE, Chen E, Fok AK, Walker H, Lim A, Nicholls EF, Cole S, Kobor MS. 2009 Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl Acad. Sci. USA 106, 14 716-14 721. (doi:10.1073/pnas. 0902971106)
10. Taylor SE, Lehman BJ, Kiefe CI, Seeman TE. 2006 Relationship of early life stress and psychological functioning to adult C-reactive protein in the coronary artery risk development in young adults study. Biol. Psychiatry 60, 819-824. (doi:10.1016/j. biopsych.2006.03.016)
11. McDade TW, Hawkley LC, Cacioppo JT. 2006 Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago Health, Aging, and Social Relations Study. Psychosom. Med. 68, 376-381. (doi:10.1097/01. psy.0000221371.43607.64)
12. Ballou SP, Kushner I. 1992 C-reactive protein and the acute phase response. Adv. Internal Med. 37, 313-336.
13. Black S, Kushner I, Samols D. 2004 C-reactive protein. J. Biol. Chem. 279, 48 487-48 490. (doi:10.1074/jbc.R400025200)
14. Du Clos TW. 2000 Function of C-reactive protein. Ann. Med. 32, 274-278. (doi:10.3109/078538900 09011772)
15. Berg AH, Scherer PE. 2005 Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939-949. (doi:10.1161/01.RES.0000163635.62927.34)
16. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. 1998 Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98, 731-733. (doi:10.1161/01.CIR.98.8.731)
17. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334. (doi:10.1001/jama.286.3.327)
18. Kuo H-K, Bean JF, Yen C-J, Leveille SG. 2006 Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J. Gerontol. A-Biol. Sci. Med. Sci. 61, 380-387. (doi:10.1093/gerona/61.4.380)
19. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. 2007 Inflammation biomarkers and nearterm death in older men. Am. J. Epidemiol. 165, 684-695. (doi:10.1093/aje/kwk057)
20. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Heimovitz H, Cohen HJ, Wallace R. 1999 Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106, 516-512. (doi:10.1016/ S0002-9343(99)00066-2)
21. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. 2006 Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav. Immun. 20, 498-504. (doi:10.1016/j.bbi.2005.10.003)
22. Nazmi A, Victora CG. 2007 Socioeconomic and racial/ ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7, 212. (doi:10.1186/1471-2458-7-212)
23. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Hanyu N, Seeman T. 2007 Socioeconomic position, race/ ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation 116, 2383-2390. (doi:10.1161/CIRCULATIONAHA.107.706226)
24. McDade TW, Lindau ST, Wroblewski K. 2011 Predictors of C-reactive protein in the National Social Life, Health, and Aging Project. J. Gerontol. B-Psychol. Sci. Soc. Sci. 66, 129-136. (doi:10.1093/ geronb/gbq008)
25. Hemingway H, Shipley M, Mullen MJ, Kumari M, Brunner E, Taylor M, Donald AE, Deanfield JE, Marmot M. 2003 Social and psychosocial influences on inflammatory markers and vascular function in civil servants (The Whitehall II study). Am. J. Cardiol. 92, 984-987. (doi:10.1016/S0002-9149 (03)00985-8)
26. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. 2007 Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl Acad. Sci. USA 104, 1319-1324. (doi:10.1073/pnas. 0610362104)
27. McDade TW, Rutherford J, Adair L, Kuzawa CW. 2010 Early origins of inflammation: microbial exposures in infancy predict lower levels of Creactive protein in adulthood. Proc. R. Soc. B 277, 1129-1137. (doi:10.1098/rspb.2009.1795)
28. Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Smith GD, Watt G. 2004 Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscl. Throm. Vas. 24, 583-587. (doi:10.1161/01.atv.0000118277.41584.63)
29. Tzoulaki I et al. 2008 Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study. Eur. Heart J. 29, 1049-1056. (doi:10. 1093/eurheartj/ehn105)
30. Kramer MS. 2000 Invited commentary: association between restricted fetal growth and adult chronic disease: it is causal? Is it important? Am. J. Epidemiol. 152, 605-608. (doi:10.1093/aje/152.7.605)
31. Shanks N, Lightman SL. 2001 The maternalneonatal neuro-immune interface: are there longterm implications for inflammatory or stress-related disease? J. Clin. Invest. 108, 1567-1573. (doi:10. 1172/JCI14592)
32. Metzger MW, McDade TW. 2010 Breastfeeding as obesity prevention in the United States: a sibling difference model. Am. J. Hum. Biol. 22, 291-296. (doi:10.1002/ajhb.20982)
33. American Academy of Pediatrics. 2012 Breastfeeding and the use of human milk. Pediatrics 129, e827-e841. (doi:10.1542/peds.2011-3552)
34. UNICEF United Kingdom. 2013 Government recommendations. See http://www.unicef.org.uk/ BabyFriendly/About-Baby-Friendly/Breastfeeding-inthe-UK/Government-recommendations/.
35. CDC. 2012 Breastfeeding report card 2012, United States. See http://www.cdcgov/breastfeeding/data/ reportcard2htm.
36. Li R, Darling N, Maurice E, Barker L, Grummer-Strawn LM. 2005 Breastfeeding rates in the United States by characteristics of the child, mother, or family: the 2002 National Immunization Survey. Pediatrics 115, e31-e37. (doi:10.1542/peds. 2004-0481)
37. Blumenshine P, Egerter S, Barclay CJ, Cubbin C, Braveman PA. 2010 Socioeconomic disparities in adverse birth outcomes: a systematic review. Am. J. Prev. Med. 39, 263-272. (doi:10.1016/j. amepre.2010.05.012)
38. Braveman P, Barclay C. 2009 Health disparities beginning in childhood: a life-course perspective. Pediatrics 124(Suppl. 3), S163-S175. (doi:10.1542/ peds.2009-1100D)
39. Wooldridge JM. 2006 Introductory econometrics, 3. Mason, OH: Aufl Thomson South-Western.
40. Paneth N, Susser M. 1995 Early origin of coronary heart disease (the Barker hypothesis). Br. Med. J. 310, 411-412. (doi:10.1136/bmj.310.6977.411)
41. Harris KM. 2011 Design features of Add Health. See http://www.cpcuncedu/projects/addhealth/data/ guides/design%20paper%20WI-IVpdf.
42. Macy EM, Hayes TE, Tracy RP. 1997 Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43, 52-58.
43. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. 2001 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47, 444-450.
44. Entzel P, Whitsel EA, Richardson A, Tabor J, Hallquist S, Hussey J, Halpern CT, Harris KM. 2009 Cardiovascular and anthropometric measures. See http://www.cpcuncedu/projects/addhealth/data/ guides/Wave%20IV%20cardiovascular%20and%20anthropometric%20documentation %20110209pdf.
45. McDade TW, Williams S, Snodgrass JJ. 2007 What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44, 899-925. (doi:10.1353/dem.2007.0038)
46. McDade TW, Burhop J, Dohnal J. 2004 High sensitivity enzyme immunoassay for C reactive protein in dried blood spots. Clin. Chem. 50, 652-654. (doi:10.1373/clinchem.2003.029488)
47. Lucas A, Fewtrell MS, Cole TJ. 1999 Fetal origins of adult disease: the hypothesis revisited. Br. Med. J. 319, 245-249. (doi:10.1136/bmj.319.7204.245)
48. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng DL, Heiss G. 2007 Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. Eur. J. Epidemiol. 22, 55-66. (doi:10. 1007/s10654-006-9082-1)
49. Schaffler A, Muller-Ladner U, Scholmerich J, Buchler C. 2006 Role of adipose tissue as an inflammatory organ in human diseases. Endocr. Rev. 27, 449-467. (doi:10.1210/er.2005-0022)
50. Harder T, Bergmann R, Kallischnigg G, Plagemann A. 2005 Duration of breastfeeding and risk of overweight: a meta-analysis. Am. J. Epidemiol. 162, 397-403. (doi:10.1093/aje/kwi222)
51. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. 2002 A comparison of methods to test mediation and other intervening variable effects. Psychol. Methods 7, 83. (doi:10.1037/1082-989X.7.1.83)
52. Halfon N, Hochstein M. 2002 Life course health development: an integrated framework for developing health, policy, and research. Milbank Q 80, 433-479. (doi:10.1111/1468-0009.00019)
53. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. 1999 Long-term effects of pravastatin on plasma concentration of C-reactive protein. The cholesterol and recurrent events (CARE) investigators. Circulation 100, 230-235. (doi:10.1161/01.CIR.100.3.230)
54. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto Jr AM. 2001 Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl. J. Med. 344, 1959-1965. (doi:10.1056/ NEJM200106283442601).
55. Albert MA, Danielson E, Rifai N, Ridker PM. 2001 Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286, 64-70. (doi:10.1001/jama.286.1.64)
56. Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, Willett WC, Buka SL. 1999 Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology 10, 774-777. (doi:10.1097/00001648-199911000-00022)
57. Li R, Scanlon KS, Serdula MK. 2008 The validity and reliability of maternal recall of breastfeeding practice. Nutr. Rev. 63, 103-110. (doi:10.1111/j. 1753-4887.2005.tb00128.x)
58. Ridker PM, Hennekens CH, Buring JE, Rifai N. 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl. J. Med. 342, 836-843. (doi:10.1056/nejm200003233421202)
59. Albert MA, Glynn RJ, Buring J, Ridker PM. 2004 C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am. J. Cardiol. 93, 1238-1242. (doi:10.1016/j.amjcard.2004.01.067)
60. Bhuiyan AR, Srinivasan SR, Chen W, Azevedo MJ, Berenson GS. 2011 Influence of low birth weight on C-reactive protein in asymptomatic younger adults: the Bogalusa Heart Study. BMC Res. Notes 4, 71. (doi:10.1186/1756-0500-4-71)
61. Williams M, Williams S, Poulton R. 2006 Breast feeding is related to C-reactive protein concentration in adult women. J. Epidemiol. Commun. H 60, 146-148. (doi:10.1136/jech.2005. 039222)
62. Rudnicka AR, Owen CG, Strachan DP. 2007 The effect of breastfeeding on cardiorespiratory risk factors in adult life. Pediatrics 119, e1107-e1115. (doi:10.1542/peds.2006-2149)
63. McDade TW. 2012 Early environments and the ecology of inflammation. Proc. Natl Acad. Sci. USA 109, 17 281-17 288. (doi:10.1073/pnas. 1202244109)
64. Field CJ. 2005 The immunological components of human milk and their effect on immune development in infants. J. Nutr. 135, 1-4.
65. Kuzawa CW, Sweet E. 2009 Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am. J. Hum. Biol. 21, 2-15. (doi:10.1002/ajhb.20822)